Background Intensity-modulated radiation therapy (IMRT) with or without concurrent
chemotherapy is widely utilized for the treatment of oropharyngeal squamous cell carcinoma …

Human papilloma virus (HPV) is a well-established causative factor in a subset of squamous
cell carcinomas of the head and neck (HNSCC). Although HPV can be detected in various …

Background Transoral robotic surgery (TORS) with concurrent neck dissection has
supplanted radiotherapy in the USA as the most common treatment for oropharyngeal …

Background Pretreatment identification of pathological extranodal extension (ENE) would
guide therapy de-escalation strategies for in human papillomavirus (HPV)-associated …

Objectives/Hypothesis To compare quality of life (QOL) of patients who underwent transoral
robotic surgery (TORS) alone, with adjuvant radiation therapy (RT), or adjuvant …

Simple Summary There is a growing body of literature demonstrating high cancer drug costs
relative to the benefits provided to patients treated on a large scale. We examined the cost …

The increasing incidence of oropharyngeal squamous cell carcinoma (OPSCC) emphasizes
the importance of optimizing treatment for the disease. Historical protocol has utilized …

Background TORS has become one of the latest surgical alternatives in the treatment of
oropharynx squamous cell carcinomas (OPSCC) and has become increasingly accepted by …

Minimally invasive surgery is a growing field in surgical oncology. After acquiring its first
Food and Drug Administration approval in 2009 for T1–T2 malignancies of the oral cavity …

Abstract Background The CheckMate 141 trial found that nivolumab improved survival for
patients with recurrent or metastatic head and neck cancer (HNC). Despite the improved …